June 2008 - This report documents behavioral and social science activities carried out by FHI 360 and its partners from September 2004 through August 2007 in support of CONRAD's Phase III clinical trial to determine the effectiveness of cellulose sulfate 6% (Ushercell) in preventing transmission of HIV.